AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $1.48 · Revenue $982.81M · 5 analysts
Est. EPS $1.43 · Revenue $985.35M · 5 analysts
Est. EPS $5.52 · Revenue $3.98B · 5 analysts
Est. EPS $1.39 · Revenue $1.01B · 3 analysts
$1.89 per share
$1.89 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $3.8B | +5.4% | +4.4% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $392.8M | +4.9% | +20.5% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +29.6% | -21.8% | -0.9% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +13.6% | -2.1% | +12.9% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +10.4% | -0.5% | +15.4% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $299.6M | -14.2% | -13.8% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +7.9% | -18.6% | -17.5% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 57.4% | +31.8% | +1.3% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.62x | +17.3% | -2.9% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $5.3B | +18.5% | +0.7% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 5.88 vs 5.71 | +3.0% | 1.36 vs 1.35 | +0.4% |
| Revenue Surprise | $3.8B vs $3.7B | +2.4% | $1.0B vs $1.0B | +1.7% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Vinczeller Shiela | officer: Chief Human Resources Officer | Common Stock | D | 765 | $130.37 |
| Sep 1, 2026 | Touya Gael | director, officer: President and CEO | Common Stock | A | 2,637 | — |
| Sep 1, 2026 | Touya Gael | director, officer: President and CEO | Stock Option | A | 9,531 | $130.92 |
| Aug 27, 2026 | Touya Gael | officer: Segment Pres., CEO Designate | Common Stock | D | 3,415 | $133.69 |
| Aug 27, 2026 | Touya Gael | officer: Segment Pres., CEO Designate | Common Stock | D | 325 | $134.55 |
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Aptar's 26 Second Quarter Results Conference Call. At this time, all participants are in a listen-only mode. We will be conducting a question and answer session. Introducing today's conference, call is Mrs. Mary Skafidas, Senior vice president, investor relations and communications. Please go ahead. Mary Skafidas: Hello, everyone, and thank you for being with us today. Joining me on today's call are Stephan Tanda, our President and CEO Vanessa Kanu, executive vice president and CFO and Gael Touya, our CEO designate and president of Aptar Pharma. Our press release and accompanying slide deck have been posted on our website under the Investor Relations page. During this call, we will be discussing certain non GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure, and the reconciliations are set forth in the press release. Please refer to the press release disseminated yesterday for the reconciliations of non GAAP measures to the most comparable GAAP measure discussed during this earnings call. As always, we will post a replay of this call on our website. I would now like to turn the conference call over to Stephan. Stephan Tanda: Thank you, Mary, and good morning, everyone. As many of you know, this is my final earnings call as CEO of Aptar before I will retire later this year. It has been a tremendous honor to lead this company and work alongside our talented teams around the world. I am incredibly proud of what we have accomplished together and confident that Aptar is well positioned for continued success. With Gael Touya assuming the role of president and CEO on September 1st, I am assured in the future success of the company and excited as a shareholder. Gael and I have worked closely together throughout this transition and for much of the last decade. I know Aptar will greatly benefit from his deep experience leadership, and vision. Gael is joining us on the call today and he will be sharing our outlook towards the end of the call. On a personal note, leading Aptar has been the greatest privilege of my career. What I will remember most is not any single accomplishment, but the people I have had the opportunity to work alongside and the relationships I have built with employees, customers, the investment community, and partners around the world. I have always believed that great companies are built by great people, and Aptar is fortunate to have an exceptional team a strong culture founded in performance and purpose, and a consistent focus on execution, innovation, agility, and value creation. While there is always more work to do, I believe Aptar is entering its next chapter from a position of strength. I am excited about the future under Gael's leadership and remain confident in the company's ability to deliver profitable growth and create long term value for shareholders. And now back to the business at hand. Let …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Stephan Tanda | President, Chief Executive Officer & Executive Director | USD 1,752,548 | Male | 1965 | Active |
Gael Touya | President of Aptar Pharma | USD 1,619,201 | Male | 1970 | Active |
Hedi Tlili | President of Aptar Closures | USD 1,102,124 | Male | 1975 | Active |
Vanessa Kanu | Executive Vice President & Chief Financial Officer | USD 1,061,325 | Female | 1978 | Active |
Xiangwei Gong | Executive VP of Strategic Group Development & President of Aptar Asia | USD 1,056,158 | Female | 1970 | Active |
Marc Prieur | President of Aptar Beauty | USD 964,014 | Male | 1966 | Active |
Alex Theodorakis | Head of Pharma Prescription | — | Male | — | Active |
Shiela Pallerne Vinczeller | Chief Human Resources Officer | — | Female | 1964 | Active |
Irene Hudson | Executive Vice President, Chief Legal Officer & Corporate Secretary | — | Female | 1977 | Active |
Mary Skafidas | Senior Vice President of Investor Relations & Communications | — | Female | — | Active |
Aditya J. Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer | — | Male | 1980 | Active |
ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.
California State Teachers Retirement System grew its position in shares of AptarGroup, Inc. (NYSE: ATR) by 24.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 77,227 shares of the industrial products company's stock after buying an additional 15,158
AptarGroup, Inc. (NYSE: ATR - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month
Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript
